Evidence map›Paper›PMID 30171005›Full record

ArticleApplied and environmental microbiology2018

Antibiotic-Resistant Escherichia coli and Class 1 Integrons in Humans, Domestic Animals, and Wild Primates in Rural Uganda.

Debora Weiss, Ryan M Wallace, Innocent B Rwego, Thomas R Gillespie, Colin A Chapman, Randall S Singer, Tony L Goldberg

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CTX-M variants on the move: Tracking resistance inOne health (Amsterdam, Netherlands) · 2026
    Article
  5. Antimicrobial Resistance and Phylo-Groups ofAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Antimicrobial Resistance in African Great Apes.Antibiotics (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Antimicrobial resistance profiles ofJAC-antimicrobial resistance · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genomic insights into ESBL-producingFrontiers in veterinary science · 2023
    Article
  18. Mini-Review: Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Debora Weiss *Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ryan M Wallace *Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Innocent B RwegoDepartment of Biosecurity, Ecosystems and Veterinary Public Health, Makerere University, Kampala, Uganda.
Thomas R GillespieDepartment of Environmental Sciences and Program in Population Biology, Ecology and Evolution, Emory University, Atlanta, Georgia, USA.
Colin A ChapmanDepartment of Anthropology, McGill University, Montreal, Quebec, Canada.
Randall S SingerDepartment of Veterinary Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, USA.
Tony L GoldbergDepartment of Pathobiological Sciences and Global Health Institute, University of Wisconsin-Madison, Madison, Wisconsin, USA tony.goldberg@wisc.edu.ORCID 0000-0003-3962-4913
University of Minnesota · USCenters for Disease Control and Prevention · USEmory University · USMcGill University · CAUniversity of Wisconsin–Madison · USWisconsin Department of Health Services · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is a global concern, although it has been studied most extensively in developed countries. We studied

Indexed as

Drug Resistance, BacterialIntegronsAmpicillinAnimalsAnimals, DomesticAnimals, WildAnti-Bacterial AgentsEscherichia coliEscherichia coli InfectionsFecesHumansLivestockMicrobial Sensitivity TestsPrimatesStreptomycinTrimethoprim, Sulfamethoxazole Drug CombinationAmpicillinAnti-Bacterial AgentsStreptomycinTrimethoprim, Sulfamethoxazole Drug CombinationAfricaantibiotic resistanceclass 1 integronsEscherichia coliprimatesprotected areas

Identifiers

PMID30171005
PMCPMC6193383
OpenAlexW2888800386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.